Investigation on maintenance hemodialysis patients with mineral and bone disorder in Anhui province, China
- PMID: 35951256
- DOI: 10.1007/s11255-022-03328-9
Investigation on maintenance hemodialysis patients with mineral and bone disorder in Anhui province, China
Abstract
Background: Chronic kidney disease-mineral bone disorder (CKD-MBD) is a common comorbidity in patients with CKD. The study aims to describe the control rates of serum-corrected calcium (Ca), phosphate (P) and intact parathyroid hormone (iPTH) and its risk factors among maintenance hemodialysis (MHD) patients in Anhui Province of China.
Methods: The study was conducted in 27 hemodialysis centers of Anhui Province between January 1st 2020 and December 31th 2020. Chi-square test was used to compare the control rates of serum-corrected Ca, P and iPTH between the present study and DOPPS 4 or Anhui Province in 2014. Binary logistic regression analysis was used to explore the risk factors of the control rates of serum-corrected Ca, P and iPTH.
Results: A total of 3 025 MHD patients were recruited in this study, with a mean age of 54.8 (SD: 12.8) years, and 60.1% were males. According to the Chinese Diagnosis and Treatment Guidelines for CKD-MBD, the control rates of serum-corrected Ca, P and iPTH in the present study were 57.9%, 20.0% and 56.0%, respectively. Based on KDOQI guidelines (2003), the control rates of the above indicators were 43.1%, 35.3% and 22.3%, respectively. The control rates of serum-corrected Ca, P and iPTH in this study were lower than those of DOPPS 4 (P < 0.001). Compared to the results of Anhui Province in 2014, the control rate of corrected Ca was higher (P < 0.001) and the control rate of iPTH was lower (P = 0.005). Age, residential area, BMI, dialysis vintage, albumin and hemoglobin levels were factors of serum-corrected Ca, P and iPTH not within target range.
Conclusion: The control rates of serum-corrected Ca, P and iPTH in MHD patients in Anhui Province are relatively low. Monitoring and management should be strengthened to improve the prognosis of patients undergoing dialysis.
Keywords: Chronic kidney disease; Hemodialysis; Mineral and bone disorder.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.
Similar articles
-
Mineral and bone disorder in hemodialysis patients in the Tibetan Plateau: a multicenter cross-sectional study.Ren Fail. 2019 Nov;41(1):636-643. doi: 10.1080/0886022X.2019.1635892. Ren Fail. 2019. PMID: 31269846 Free PMC article.
-
Clinical Epidemiology of Mineral Bone Disorder Markers in Prevalent Hemodialysis Patients in the Xinjiang Uyghur Autonomous Region in China.Biomed Res Int. 2017;2017:2516934. doi: 10.1155/2017/2516934. Epub 2017 Feb 19. Biomed Res Int. 2017. PMID: 28299319 Free PMC article.
-
High prevalence of biochemical disturbances of chronic kidney disease - mineral and bone disorders (CKD-MBD) in a nation-wide peritoneal dialysis cohort: are guideline goals too hard to achieve?J Bras Nefrol. 2021 Apr-Jun;43(2):173-181. doi: 10.1590/2175-8239-JBN-2020-0147. J Bras Nefrol. 2021. PMID: 33538758 Free PMC article.
-
Efficacy and safety of lanthanum carbonate on chronic kidney disease-mineral and bone disorder in dialysis patients: a systematic review.BMC Nephrol. 2013 Oct 17;14:226. doi: 10.1186/1471-2369-14-226. BMC Nephrol. 2013. PMID: 24134531 Free PMC article.
-
Restoration of parathyroid function after change of phosphate binder from calcium carbonate to lanthanum carbonate in hemodialysis patients with suppressed serum parathyroid hormone.J Ren Nutr. 2015 Mar;25(2):242-6. doi: 10.1053/j.jrn.2014.10.013. Epub 2014 Dec 30. J Ren Nutr. 2015. PMID: 25556148 Review.
Cited by
-
Association between neutrophil percentage-to-albumin ratio and mortality in Hemodialysis patients: insights from a prospective cohort study.BMC Nephrol. 2025 Mar 4;26(1):112. doi: 10.1186/s12882-025-04027-0. BMC Nephrol. 2025. PMID: 40038629 Free PMC article.
References
-
- Chen H, Wang DG, Qian GR, Huang YY, Hu B, Wang CF et al (2015) Investigation of maintenance hemodialysis patients with mineral and bone disorder in Anhui Province. Chin J Nephrol 31(7):509–515. https://doi.org/10.3760/cma.j.issn.1001-7097.2015.07.006 - DOI
-
- Zhang L, Zhao MH, Zuo L, Wang Y, Yu F, Zhang H et al (2019) China kidney disease network (CK-NET) 2015 annual data report. Kidney Int Suppl 9(1):e1–e81. https://doi.org/10.1016/j.kisu.2018.11.001 - DOI
-
- Zhang L, Zhao MH, Zuo L, Wang Y, Yu F, Zhang H, Wang H, CK-NET Work Group (2020) China kidney disease network (CK-NET) 2016 annual data report. Kidney Int Suppl 10(2):e97–e185. https://doi.org/10.1016/j.kisu.2020.09.001 - DOI
-
- National Clinical Research Center For Kidney Disease (2019) Summary of Chinese guidelines for the diagnosis and treatment of chronic kidney disease with mineral and bone abnormalities in. J Nephrol Daily Transplant 28(1):52–57. https://doi.org/10.3969/j.issn.1006-298X.2019.01.012 - DOI
-
- Fernández-Martín JL, Martínez-Camblor P, Dionisi MP, Floege J, Ketteler M, London G et al (2015) Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study. Nephrol Dial Transplant 30(9):1542–1551. https://doi.org/10.1093/ndt/gfv099 - DOI
MeSH terms
Substances
Grants and funding
- 2019xkj140/Science Foundation of Anhui Medical University
- 2020LCZD01/Clinical Research Incubation Program of The Second Hospital of Anhui Medical University
- 2020lcxk022/National Key Clinical Specialty Discipline Construction Program of China
- 2021lcxk032/National Key Clinical Specialty Discipline Construction Program of China
LinkOut - more resources
Full Text Sources
Medical